Cetera Investment Advisers’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.69M | Sell |
29,980
-6,943
| -19% | -$405K | ﹤0.01% | 2440 |
|
|
2025
Q4 | $2.19M | Sell |
36,923
-3,156
| -8% | -$172K | ﹤0.01% | 2129 |
|
|
2025
Q3 | $2.17M | Buy |
40,079
+15,783
| +65% | +$903K | ﹤0.01% | 2101 |
|
|
2025
Q2 | $1.34M | Sell |
24,296
-4,959
| -17% | -$292K | ﹤0.01% | 2139 |
|
|
2025
Q1 | $2.07M | Buy |
29,255
+17,931
| +158% | +$1.21M | ﹤0.01% | 1726 |
|
|
2024
Q4 | $744K | Buy |
11,324
+3,870
| +52% | +$259K | ﹤0.01% | 2374 |
|
|
2024
Q3 | $524K | Sell |
7,454
-4,238
| -36% | -$354K | ﹤0.01% | 2611 |
|
|
2024
Q2 | $963K | Sell |
11,692
-4,357
| -27% | -$363K | ﹤0.01% | 2103 |
|
|
2024
Q1 | $1.4M | Buy |
16,049
+11,030
| +220% | +$987K | ﹤0.01% | 1806 |
|
|
2023
Q4 | $484K | Buy |
5,019
+194
| +4% | +$17.2K | ﹤0.01% | 1509 |
|
|
2023
Q3 | $427K | Buy |
4,825
+238
| +5% | +$21.2K | ﹤0.01% | 1508 |
|
|
2023
Q2 | $398K | Buy |
4,587
+1,057
| +30% | +$99.5K | ﹤0.01% | 1578 |
|
|
2023
Q1 | $343K | Buy |
3,530
+59
| +2% | +$6.12K | ﹤0.01% | 1628 |
|
|
2022
Q4 | $359K | Buy |
3,471
+371
| +12% | +$34.8K | ﹤0.01% | 1549 |
|
|
2022
Q3 | $263K | Sell |
3,100
-189
| -6% | -$16.8K | 0.01% | 1358 |
|
|
2022
Q2 | $273K | Sell |
3,289
-2,670
| -45% | -$213K | ﹤0.01% | 1482 |
|
|
2022
Q1 | $459K | Sell |
5,959
-511
| -8% | -$42.8K | 0.01% | 1217 |
|
|
2021
Q4 | $572K | Buy |
6,470
+370
| +6% | +$30.5K | 0.01% | 1105 |
|
|
2021
Q3 | $471K | Buy |
6,100
+483
| +9% | +$38.1K | 0.01% | 1178 |
|
|
2021
Q2 | $469K | Buy |
+5,617
| New | +$445K | 0.01% | 1154 |
|
|
2021
Q1 | – | Sell |
-2,695
| Closed | -$236K | – | 1609 |
|
|
2020
Q4 | $236K | Buy |
+2,695
| New | +$214K | ﹤0.01% | 1376 |
|
Other funds holding BMRN
VCM
VPM
